Table 6.
The Cosavirus prevalence based on subgroups and studies heterogeneity.
| Characteristics | Categories |
No. of Data sets |
Pooled prevalence (%) (95% CI) |
Heterogeneity | ||
|---|---|---|---|---|---|---|
| Q value | P-value | I2% | ||||
| Overall | – | 16 | 0.8 (0.4–1.5) | 28.29 | 0.000 | 92.932 |
| WHO regions | Africa | 1 | 1.0 (0.2–3.9) | 0.000 | 1.000 | 0.000 |
| America | 2 | 4.2 (2.6–6.6) | 1.022 | 0.312 | 2.185 | |
| Asia | 9 | 0.7 (0.3–1.4) | 21.240 | 0.007 | 62.335 | |
| Europe | 4 | 0.2 (0.1–0.7) | 0.377 | 0.945 | 0.000 | |
| Genotype | HCoSV-A | 3 | 0.5 (0.1–2.1) | 6.292 | 0.043 | 68.213 |
| HCoSV-C | 1 | 0.1 (0.0–0.6) | 0.000 | 1.000 | 0.000 | |
| HCoSV-D | 2 | 0.2 (0.0–0.7) | 0.837 | 0.360 | 0.000 | |
| Co-infection | NoV | 2 | 0.2 (0.0–1.1) | 1.420 | 0.233 | 29.561 |
| EV | 3 | 0.7 (0.1–3.3) | 5.932 | 0.052 | 66.286 | |
| RoV | 3 | 0.4 (0.2–0.8) | 1.384 | 0.500 | 0.000 | |
| AdV | 5 | 0.6 (0.1–2.1) | 9.329 | 0.053 | 57.122 | |
| Age | <5 | 10 | 0.5 (0.2–1.1) | 21.031 | 0.013 | 57.207 |
| <15 | 7 | 1.2 (0.5–2.9) | 18.564 | 0.005 | 67.680 | |
| >15 | 2 | 0.4 (0.1–1.8) | 0.319 | 0.517 | 0.000 | |